Characteristics of studies | N (%) |
---|---|
Objective of segmentation | |
 Health grouping or profiling | 71 (48.0) |
 Assess risk of diabetic related complications across groups | 57 (38.5) |
 Assess non-diabetes metabolic derangements (e.g. lipid, blood pressure) across groups | 42 (28.4) |
 Assess diabetic control across groups | 40 (27.0) |
 Assess healthcare utilization | 17 (11.5) |
 Assess mortality | 16 (10.8) |
 Assess treatment outcomes | 10 (6.8) |
 Assess quality of life across groups | 4 (2.7) |
 Assess psychological symptoms across groups | 3 (2.0) |
 Assess risk of psychological outcomes across groups | 3 (2.0) |
 Asses treatment adherence | 3 (2.0) |
 Assess accessibility to providers and healthcare services | 1 (0.7) |
 Assess cognitive related outcomes across groups | 1 (0.7) |
 Assess physical function across groups | 1 (0.7) |
 Assess obesity rates across groups | 1 (0.7) |
 Assess pregnancy related outcomes | 1 (0.7) |